Abstract
Get full access to this article
View all access options for this article.
References
1.
Wolf
S. M.
Gupta
R.
Kohlepp
P.
, “Gene Therapy Oversight: Lessons for Nanobiotechnology,” Journal of Law, Medicine & Ethics 37 , no. 4 (2009 ): 659 –684 .
2.Id.
3.
Fredrickson
D. S.
, The Recombinant DNA Controversy (Washington, D.C. : American Society of Microbiology Press , 2001 ): at 278 .
4.Id.
5.
See
Wolf
, supra , note 1.
6.
Scott
C.
, “What Stem Cell Therapy Can Learn from Gene Therapy,” Nature Reports Stem Cells (2008 ), published online September 4, 2008 .